Navigation Links
An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes

------------------------------------------- --------- + Intent to Treat Population using last observation on study prior to pioglitazone rescue therapy. ++ Least squares means adjusted for prior antihyperglycemic therapy and baseline value. ss. pless than0.001 compared to placebo + metformin.
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
3. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
4. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
5. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
6. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
7. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
10. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
11. Investigational Study Evaluates the Effectiveness of Aripiprazole in Adolescents With Schizophrenia
Post Your Comments:
(Date:12/4/2009)... Shore and E. David Crawford presented results for prostate-specific ... end points of biochemical recurrence rate in a Phase ... or monthly leuprolide in prostate cancer patients during the ... received FIRMAGON 240/80 mg/month had a recurrence rate of ...
(Date:12/3/2009)... Allen Medical Systems, a subsidiary of Hill-Rom Holdings, Inc. ... of its new Allen Amatech(TM) OEM (Original Equipment Manufacturer) ... The website reinforces the Allen Amatech(TM) brand identity and ... with detailed descriptions and design specifications for the products. ...
(Date:12/3/2009)... 3 BioMed Realty Trust, Inc. (NYSE: BMR ... lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) for ... space at The Landmark at Eastview campus in Tarrytown, New ... lease of additional space was completed approximately two months after ...
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream 49191 1Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream 49191 2Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream 49191 3NxStage 28R 29 Announces Medisystems 28R 29 Bloodline Distribution Agreement with Gambro 49188 1NxStage 28R 29 Announces Medisystems 28R 29 Bloodline Distribution Agreement with Gambro 49188 2NxStage 28R 29 Announces Medisystems 28R 29 Bloodline Distribution Agreement with Gambro 49188 3Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle free Symphony 28TM 29 Transdermal Continuous Glucose Monitoring Syste 49185 1Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle free Symphony 28TM 29 Transdermal Continuous Glucose Monitoring Syste 49185 2Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle free Symphony 28TM 29 Transdermal Continuous Glucose Monitoring Syste 49185 3Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle free Symphony 28TM 29 Transdermal Continuous Glucose Monitoring Syste 49185 4
... QMed, Inc.,(Nasdaq: QMED ) today announced it ... the Centers for Medicare and Medicaid Services (CMS) ... Northern,California., In 2002, The CMS selected 15 ... coordinated care services to Medicare fee-for-service,beneficiaries with complex ...
... Promise, Enbrel Will Remain the Clinical Gold Standard Through 2016, ... ... Resources, WALTHAM, Mass., April 7, 2008 Decision Resources, one,of ... issues, finds that a drug,s effect on,inhibiting/slowing the progression of structural ...
Other Medicine Technology:QMed, Inc. Receives 2-Year Extension of Medicare Coordinated Care Demonstration Project by CMS 2Current and Emerging Drugs Have No Advantage Over Enbrel in Inhibiting/Slowing the Progression of Rheumatoid Arthritis 2Current and Emerging Drugs Have No Advantage Over Enbrel in Inhibiting/Slowing the Progression of Rheumatoid Arthritis 3
(Date:12/5/2009)... Youngest Babies, This Type of Blood Cancer Is Most ... 5 Pediatric oncologists have identified specific genes, dubbed ... an often-fatal form of leukemia in infants. By more ... predict which infants may benefit from particular treatments. ...
(Date:12/5/2009)... AVIVA today announced the launch of International Solutions, an innovative new ... of its UK equivalent. In addition to offering customers the flexibility ... their needs and budgets, International Solutions enables customers to tailor their ... , ...
(Date:12/4/2009)... of KPMG LLP employees came together in more than 90 ... which combines the audit, tax and advisory firm,s support for ... reflects our firm,s long history of volunteerism. Instead of holiday ... brighten the holidays for some children," said Tim Flynn, Chairman ...
(Date:12/4/2009)... Mo., Dec. 4 The large, two-day free health clinic ... Kansas City on Wednesday and Thursday is not just for ... has not seen a doctor recently. All participants in the ... people who attended the three previous large free clinic events ...
(Date:12/4/2009)... cancers, particularly Ewing sarcomas and tumors of the central ... December 4 in the Journal of the National ... there is limited research on late recurrence (after 5 ... patients. , Karen Wasilewski-Masker, M.D., of the Aflac Cancer ...
Breaking Medicine News(10 mins):Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Free Health Clinic Event Is Not Just for the Sick 2
... HOUSTON, July 25 The Elekta Family of ... solutions at the 2008,American Association of Physicists in ... of Elekta, IMPAC and CMS are delivering,cutting-edge radiation ... process to create a better experience for,patients, as ...
... July 25 AutoGenomics, Inc. today,announced that it has ... and Exchange Commission relating to the proposed initial public,offering ... shares of common,stock to be offered, all of which ... price range for the offering, have not yet been,determined., ...
... can be toughest for those trying to drop pounds, ... Anyone who has avoided Monday morning weigh-ins knows this ... Now, researchers have some science to back up dieters, ... eat more on the weekend, even when they,re trying ...
... educational meeting regarding age-related macular degeneration especially designed for seniors. The ... Merritts Road, Farmingdale, NY 11735, 1:00 to 2:00 p.m. on Friday, ... phone number for pre-registration is (516) 939-6100. , ... ...
... Association (DIA) and the Food and Drug Administration (FDA) will host ... (September 15 -16; Bethesda, MD) and the Critical Path Transporter Workshop ... ... (PRWEB) July 25, 2005-- The http://www.diahome.org/ [Drug Information Association ...
... law firm represents Pickerington man who contracted E. coli from ground ... ... Ohio (Lexis Nexis) July 25, 2008 -- http://www.donaheyohioinjurylawyers.com [The ... in central Ohio, has filed a product liability lawsuit in Franklin ...
Other Medicine News:Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2Health News:Weekends Tough on the Diet 2Health News:Weekends Tough on the Diet 3Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3Health News:Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court 2
... , Standby: A standby switch maintains power to ... 1 s (1 pulse/s) , Tetanus: 100 ... s) , Output Current: Adjustable from 0-70 mA ... (200-us duration) , Indicators: Battery LED (green) indicates ...
... A range of easy to use ... RDG nerve locator, peripheral nerve stimulator, and ... insulating pole, plastic hub, and pencil point ... an inexpensive, practical and easy to use ...
Based on the original MS-1 design the new MS-1B includes low battery detection, FET based output circuitry and enhanced battery compartment....
... for the delivery and monitoring of inhaled ... is a fully integrated, innovative instrument used ... therapy. The INOvent delivery system works in ... machine) to deliver a constant concentration of ...
Medicine Products: